In September 2019, BioNTech received a capital contribution of US$55 million from the Bill & Melinda Gates Foundation, with the potential to double the investment in the future, two months before the Covid-19 outbreak. Gates Foundation to Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally Ref: https://www.gatesfoundation.org/ideas/media-center/press-releases/2023/10/mrna-vaccine-manufacturing-africa Gates Foundation Awards $20 Million to … Continue reading BioNTech received a capital contribution of US$55 million from the Bill & Melinda Gates Foundation two months before the Covid-19 pandemic.